On 16 February, Repros Therapeutics Inc. (NASDAQ:RPRX) announced that it has fully randomized a Phase 2 double-blind placebo controlled proof of concept study of enclomiphene in conjunction with rigorous diet and exercise in the treatment of obese secondary hypogonadal men. The study over enrolled its target of 45 subjects well ahead of schedule in 27 calendar days from the first subject enrolled at five clinical sites.
Repros Therapeutics Inc. (NASDAQ:RPRX) belongs to Healthcare sector. Its weekly performance is -1.81%. On last trading day company shares ended up at $0.83.
Trillium Therapeutics Inc. (NASDAQ:TRIL)‘s stock had its “outperform” rating reiterated by analysts at Cowen and Company in a research report issued on Wednesday, Analyst Ratings.Net reports.
Trillium Therapeutics Inc. (NASDAQ:TRIL) shares decreased -5.53% in last trading session and ended the day at $7.26. Trillium Therapeutics Inc. (NASDAQ:TRIL) quarterly performance is -51.70%.
Shoe Carnival Inc. (NASDAQ:SCVL) announced fourth quarter 2015 earnings results will be released on Thursday, March 17, 2016 after the market close. The Company will host its quarterly conference call to discuss fourth quarter and fiscal year 2015 results at 4:30 p.m. Eastern Time.
On 01 March, Shoe Carnival Inc. (NASDAQ:SCVL) shares moved up 1.36% and was closed at $23.89. SCVL EPS growth in last 5 year was 9.70%. Shoe Carnival Inc. (NASDAQ:SCVL) year to date (YTD) performance is 3.26%.
Kyocera Corp. (NYSE:KYO) said that, it is showing off a solar-powered smartphone display at last year’s Mobile World Congress. Well, the company has returned in 2016 with a much-improved prototype, and says that this type of technology could start appearing in consumer phones in the near future.
Kyocera Corp. (NYSE:KYO) ended the last trading day at $44.68. Company weekly volatility is calculated as 1.35% and price to cash ratio as 2.89. Kyocera Corp. (NYSE:KYO) showed a weekly performance of 2.22%.
On 25 February, FTI Consulting, Inc. (NYSE:FCN) released its financial results for the quarter and full year ended December 31, 2015. For the quarter, revenues increased 4.0 percent to $442.2 million compared to $425.2 million in the prior year quarter.
FTI Consulting, Inc. (NYSE:FCN) shares moved up 4.31% in last trading session and ended the day at $34.33. FCN Gross Margin is 34.20% and its return on assets is 2.80%. FTI Consulting, Inc. (NYSE:FCN) quarterly performance is -10.58%.